Vikram Arya

Targeting microbial biofilms: current and prospective therapeutic strategies

In silico ADME/T modelling for rational drug design

Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections

Pharmacokinetic aspects of biotechnology products

Global strategy for asthma management and prevention: GINA executive summary

Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections

Mesoporous Materials for Drug Delivery

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years

Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma

Clinical consequences of polypharmacy in elderly

Full publication of results initially presented in abstracts

ProTox-II: a webserver for the prediction of toxicity of chemicals

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy

Slow Release Formulations of Inhaled Rifampin

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

Regulatory Perspectives on Designing Pharmacokinetic Studies and Optimizing Labeling Recommendations for Patients With Chronic Kidney Disease

Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches: The metabolism of dynorphin A1–13 and related fragments in human plasma

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide